# Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy

> **NCT03958643** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 70 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03958643
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-24
- **Primary completion:** 2021-05-01
- **Final completion:** 2022-02-08
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03958643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03958643, "Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03958643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*